CoChat

Local Production of Activated Factor X in Atherosclerotic Plaque Induced Vascular Smooth Muscle Cell Senescence

Open access

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

Our previous study demonstrated that coagulation factor Xa (FXa) induced endothelial cell senescence, resulting in inflammation and impaired angiogenesis. This mechanism is dictated through protease-activated receptors, PARs, insulin-like growth factor-binding protein 5 (IGFBP-5), and p53. Activation of PARs contributes to the pathophysiology of several chronic inflammatory diseases, including atherosclerosis. Thus, we speculated that similar mechanism might participate in the progression of atherosclerotic plaques. In the present study, we successfully identified the cells that produced FX/Xa in atherosclerosis using human atherosclerotic plaques obtained from carotid endarterectomy. In situ hybridization for FX revealed that FX was generated in vascular smooth muscle cells (VSMC), inflammatory cells, and endothelial cells. Then, we examined the effects of FXa on the growth of VSMC in vitro. The present study revealed that chronic FXa stimulation significantly induced the senescence of VSMC with concomitant upregulation of IGFBP-5 and p53. Inhibition of FXa signaling with rivaroxaban or knock down of IGFBP-5 significantly reduced FXa-induced VSMC senescence and inflammatory cytokine production. Finally, we confirmed that FXa and IGFBP-5 are co-distributed in atherosclerotic plaques. In conclusion, induction of senescence of VSMC induced by locally produced FX/Xa may contribute to the progression of atherosclerosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-17508-6

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 In situ hybridization of coagulation FX in human atherosclerotic plaques. (A) In situ hybridization of human atherosclerotic plaques obtained from the patients subjected to carotid endarterectomy with an antisense probe to human FX. (B) This panel shows αSMA and DAPI staining. (C) The sense probe strand shows no specific hybridization. (D) Control carotid artery samples with antisense probe demonstrated much weaker signals compared to the samples from patients. (E,F) A higher-magnification image shows strong positive staining in VSMCs (E) and inflammatory cells (F).
Figure 1 In situ hybridization of coagulation FX in human atherosclerotic plaques. (A) In situ hybridization of human atherosclerotic plaques obtained from the patients subjected to carotid endarterectomy with an antisense probe to human FX. (B) This panel shows αSMA and DAPI staining. (C) The sense probe strand shows no specific hybridization. (D) Control carotid artery samples with antisense probe demonstrated much weaker signals compared to the samples from patients. (E,F) A higher-magnification image shows strong positive staining in VSMCs (E) and inflammatory cells (F).CC BY · PubMed Central
Figure 2 Induction of SMC senescence by FXa through IGFBP-5. (A–C) Human aortic VSMCs were treated every other day for 14 days with FXa (50 nM), FXa (50 nM) with rivaroxaban (10 μM), or recombinant IGFBP-5 (rIGFBP-5, 100 ng/mL). Additionally, IGFBP-5 was overexpressed in human aortic VSMCs using pIGFBP5. (A) Senescent cells were detected by senescence associated β-galactosidase staining (SA-β-gal staining). (B) The fractions of SA-β gal-positive VSMCs. *, **P < 0.05 vs. control (CTRL) and FXa, respectively. n = 10. (C) Over-expression of IGFBP-5 increased the fractions of SA-β Gal-positive VSMCs. *P < 0.05 vs. control (CTRL). n = 10. (D–F) FXa significantly increased the expression of IGFBP-5 and p53, and similarly, rIGFBP-5 up-regulated p53 expression in human aortic VSMCs. However, rivaroxaban or IGFBP-5 siRNA remarkably reduced FXa-induced IGFBP-5 and p53 up-regulation. *, **P < 0.05 vs. control and FXa, respectively. n = 4.
Figure 2 Induction of SMC senescence by FXa through IGFBP-5. (A–C) Human aortic VSMCs were treated every other day for 14 days with FXa (50 nM), FXa (50 nM) with rivaroxaban (10 μM), or recombinant IGFBP-5 (rIGFBP-5, 100 ng/mL). Additionally, IGFBP-5 was overexpressed in human aortic VSMCs using pIGFBP5. (A) Senescent cells were detected by senescence associated β-galactosidase staining (SA-β-gal staining). (B) The fractions of SA-β gal-positive VSMCs. *, **P < 0.05 vs. control (CTRL) and FXa, respectively. n = 10. (C) Over-expression of IGFBP-5 increased the fractions of SA-β Gal-positive VSMCs. *P < 0.05 vs. control (CTRL). n = 10. (D–F) FXa significantly increased the expression of IGFBP-5 and p53, and similarly, rIGFBP-5 up-regulated p53 expression in human aortic VSMCs. However, rivaroxaban or IGFBP-5 siRNA remarkably reduced FXa-induced IGFBP-5 and p53 up-regulation. *, **P < 0.05 vs. control and FXa, respectively. n = 4.CC BY · PubMed Central
Figure 3 Senescence-associated inflammatory responses and impaired the proliferation. (A) Relative mRNA expression of IL-1β/GAPDH, IL-6/GAPDH, MCP-1/GAPDH, and IGFBP-5/GAPDH in FXa treated human aortic VSMCs. *, **P < 0.05 vs. control siRNA and control siRNA + FXa 50 nM, respectively. n = 3. (B) FXa-induced inflammatory cytokine expression was reduced by the direct FXa inhibitor, ribaroxban. *, **P < 0.05 vs. control and FXa 50 nM, respectively. n = 5. (C) The ability of FXa-treated human aortic VSMCs to proliferate was measured by MTS assay. *, **P < 0.05 vs. control (CTRL) and FXa (50 nM), respectively. n = 6.
Figure 3 Senescence-associated inflammatory responses and impaired the proliferation. (A) Relative mRNA expression of IL-1β/GAPDH, IL-6/GAPDH, MCP-1/GAPDH, and IGFBP-5/GAPDH in FXa treated human aortic VSMCs. *, **P < 0.05 vs. control siRNA and control siRNA + FXa 50 nM, respectively. n = 3. (B) FXa-induced inflammatory cytokine expression was reduced by the direct FXa inhibitor, ribaroxban. *, **P < 0.05 vs. control and FXa 50 nM, respectively. n = 5. (C) The ability of FXa-treated human aortic VSMCs to proliferate was measured by MTS assay. *, **P < 0.05 vs. control (CTRL) and FXa (50 nM), respectively. n = 6.CC BY · PubMed Central
Figure 4 Distribution of FXa and IGFBP-5 staining area in human atherosclerotic plaques. (A) Human atherosclerotic plaques were stained with FXa (left), IGFBP-5 (middle), and Hematoxylin-Eosin staining (right). (B,C) Higher magnification of the FXa and IGFBP-5 positive area in VSMCs (B, black arrow) and inflammatory cells (C, white arrow).
Figure 4 Distribution of FXa and IGFBP-5 staining area in human atherosclerotic plaques. (A) Human atherosclerotic plaques were stained with FXa (left), IGFBP-5 (middle), and Hematoxylin-Eosin staining (right). (B,C) Higher magnification of the FXa and IGFBP-5 positive area in VSMCs (B, black arrow) and inflammatory cells (C, white arrow).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 42

Metadata

Authors
Sanada, F., Muratsu, J., Otsu, R., Shimizu, H., Koibuchi, N., Uchida, K., Taniyama, Y., Yoshimura, S., Rakugi, H., & Morishita, R.
Affiliations
  • The University of Osaka (JP)
  • Kumamoto University (JP)
  • Hyogo Medical University (JP)
Corresponding author
  • Taniyama, Yoshiaki
  • Morishita, Ryuichi
Venue
Scientific Reports
Published
2017-12-07
Volume
7
Issue
1
Pages
17172-17172
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2771771060
Cited by
41
References
26
Citations by year
2026: 1 · 2025: 4 · 2024: 2 · 2023: 5 · 2022: 3 · 2021: 9 · 2020: 8 · 2019: 6 · 2018: 3
FWCI
3.58
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Ministry of Education, Culture, Sports, Science and Technology
  • Bayer Yakuhin
  • Japan Society for the Promotion of Science (16K08469)
Topics
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
  • Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Keywords
factor Xa, atherosclerosis, vascular smooth muscle cell senescence, protease-activated receptors, IGFBP-5, p53, rivaroxaban, inflammatory cytokines, atherosclerotic plaque, carotid endarterectomy, coagulation, endothelial cell senescence
MeSH terms
Cells, Cultured, Humans, Muscle, Smooth, Vascular, Signal Transduction, Factor Xa, Cellular Senescence, Insulin-Like Growth Factor Binding Protein 5, Plaque, Atherosclerotic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Local Production of Activated Factor X in Atherosclerotic Plaque Induced Vascular Smooth Muscle Cell Senescence. https://app.cochat.ai/papers/10.1038/s41598-017-17508-6
The paper
Sanada, F., Muratsu, J., Otsu, R., Shimizu, H., Koibuchi, N., Uchida, K., Taniyama, Y., Yoshimura, S., Rakugi, H., & Morishita, R. (2017). Local Production of Activated Factor X in Atherosclerotic Plaque Induced Vascular Smooth Muscle Cell Senescence. Scientific Reports. https://doi.org/10.1038/s41598-017-17508-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.